Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Hirofumi Nakano
Institution:
Eiju General Hospital
Observed institutions:
Jichi Medical University,
Eiju General Hospital
ORCID:
0000-0002-0798-2321
Observed ORCID:
0000-0002-0798-2321
OpenAlex ID:
A5018610678
Increased trough concentration of venetoclax when combined with itraconazole for acute myeloid leukemia
2024
·
Masao Hagihara
, Takeo Yasu
, et al.
·
Annals of Hematology
·
6
Fatty Acids Play a Critical Role in Mitochondrial Oxidative Phosphorylation in Effector T Cells in Graft-versus-Host Disease
2024
·
Hirofumi Nakano
, Kazuya Sato
, et al.
·
ImmunoHorizons
·
3
PDF
Clinical Efficacy of Imdevimab/Casirivimab for Persistent Omicron SARS-CoV-2 Infection in Patients with Hematological Malignancies
2024
·
Masao Hagihara
, Hiroyoshi Hayashi
, et al.
·
Internal Medicine
·
2
PDF
[Diffuse large B-cell lymphoma concurrent with Kaposi's sarcoma in the same lymph node in a human immunodeficiency virus-negative patient].
2024
·
Shiori Nakashima
, Shin Ohara
, et al.
·
PubMed
·
2
COVID-19-induced thrombotic microangiopathy in patients with multiple myeloma receiving carfilzomib treatment
2025
·
Kaito Takikawa
, Mana Sota
, et al.
·
International Journal of Hematology
·
1
Clinical characteristics and risk factors for pomalidomide-induced skin rash: Implications for pharmacist-led monitoring in real-world multiple myeloma care
2026
·
Tomiyuki Sugi
, Ryouta Kushi
, et al.
·
Journal of Oncology Pharmacy Practice
[Utility of next-generation sequencing for diagnosing non-secretory multiple myeloma].
2026
·
Mana Sota
, Hirofumi Nakano
, et al.
·
PubMed
[Prophylactic efficacy of tixagevimab/cilgavimab in patients with hematological neoplasms: a single-center study].
2025
·
Hirofumi Nakano
, Shiori Nakashima
, et al.
·
PubMed
[Outcomes of COVID-19 due to omicron variant infection complicated with hematological disorders].
2023
·
Masao Hagihara
, Hiroyasu Hayashi
, et al.
·
PubMed
[Analysis of anti-SARS-CoV-2 IgG antibody titers after mRNA booster vaccination in patients with nonmalignant hematological disorders].
2023
·
Masao Hagihara
, Tomiyuki Sugi
, et al.
·
PubMed
Show more works
View as search
Works count:
10
Citation count:
14
H-index:
2
I10-index:
Year
Topic
Type